Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma

N. Kathiravetpillai, M. Koeter, M. J. C. van der Sangen, G. J. Creemers, M. D. P. Luyer, H. J. T. Rutten, G. A. P. Nieuwenhuijzen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1183-1190
JournalEuropean Journal of Surgical Oncology
Volume42
Issue number8
DOIs
Publication statusPublished - Aug 2016

Keywords

  • Oesophageal adenocarcinoma
  • Neoadjuvant chemoradiotherapy
  • Interval
  • Postoperative outcome

Cite this